7th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention
The world’s largest open scientific conference on HIV/AIDS – the 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) was held at the Kuala Lumpur Convention Centre (KLCC ) in Kuala Lumpur, Malaysia from 30 June-3 July 2013.
(Kuala Lumpur, Malaysia – 30 June 2013)
DNDi & Cipla Advance Development of Paediatric 4-in-1 ARVs to Fulfill New WHO Guidelines
IAS 2013 Highlights
The Lancet Infectious Diseases, August 2013 issue, DNDi mention in IAS 2013 highlights [pdf]
DNDi co-hosted session: “Closing the Treatment Gap for Children Living with HIV” (MOSA03)
Date: Monday, July 1, 2013, 6:30-8:30 PM
Location: Mini Room 3
Organizers: UNITAID, Drugs for Neglected Diseases initiative (DNDi), and the Medicines Patent Pool (MPP)
In 2011, an estimated 3.4 million children below the age of 15 were living with HIV globally. Mortality rate can reach as high as 50% for these children who do not get treatment by the age of 2. In 2011 alone, 230,000 children were estimated to have died from AIDS-related causes. While antiretroviral treatment for children with HIV has come a long way, the treatment coverage in children at 28% still lags far behind that of adults coverage of 57%. This satellite aims to look at the bottlenecks in getting treatment to children, such as availability of point-of-care early infant diagnosis, availability of most efficacious and adapted paediatric formulations for use in resource poor settings, healthcare workers’ perception of challenges in treating children, intellectual property rights and trends in the paediatric markets. It will also look at what is required for closing the treatment gap.
- DNDi‘s 2013 pediatric HIV overview, “Urgent Need to Develop and Deliver Antiretroviral Treatment Formulations for Infants and Children with HIV/AIDS” [pdf]
- DNDi’s 2011 Perspective article in The New England Journal of Medicine: “Pediatric HIV – A Neglected Disease?” [pdf]